GW 590735
Alternative Names: 590735; GW-590735Latest Information Update: 02 Aug 2023
At a glance
- Originator GlaxoSmithKline; Ligand Pharmaceuticals
- Class Antihyperlipidaemics; Propionic acids; Small molecules; Thiazoles
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Atherosclerosis; Lipid metabolism disorders
Most Recent Events
- 18 Jul 2007 GW 590735 is still in active development
- 31 Dec 2003 Phase-II clinical trials in Atherosclerosis in USA (unspecified route)
- 31 Dec 2003 Phase-II clinical trials in Lipid metabolism disorders in USA (unspecified route)